Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Iamarangerboy who wrote (10021)	4/10/2007 12:51:39 AM
From: Robohogs	Read Replies (1) of 10280

Not as bad as it looks - almost though. On Lunesta, NRx share was up 10 bps after going down over last few weeks. TRx share was flat. SO this move was a combination of slowing growth in mkt and the timing within the month - remember weeks including the first day of a month usually do best. On Xop MDI, the news is a bit worse. First, the market overall was off slightly week over week. Second, the market share of HFA products was up slightly week over week. Third, both Teva and Sepr lost share in the HFA segment to SGP/Proventil. Xop share of TRx fell from 13.6% to 13.1%. As an aside the last 10 week TRx and NRx share numbers are below. Total New Jan 5 14.8 13.9 Jan 12 15.5 14.8 Jan 19 14.3 13.7 Jan 26 13.8 13.3 Feb 2 12.8 12.2 Feb 9 12.6 12.3 Feb 16 14.1 14.0 Feb 23 13.8 13.7 Mar 2 12.5 12.3 Mar 9 11.7 11.5 Mar 16 12.1 11.9 Mar 23 13.6 13.8 Mar 30 13.1 13.4 HFAs were about 30% of mkt in December, climbing through 40% in January and 50% in February. In March weeks, it hit as high as 2/3. Jon

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next